header3

Hit Identification through to
Development Candidate


LATEST NEWS FROMSYGNATURE

Sygnature Discovery’s drug discovery capabilities enhanced by acquisition of BMG LABTECH PHERAstar® FSX

header2

Build your career with
Sygnature Discovery

header

Your expert partner in
Drug Discovery


LATEST NEWS FROMSYGNATURE

Sygnature Discovery invests in further new technologies thanks to £190K grant from the N2 Business Growth Fund

  • Medicinal Chemistry

  • Bioscience

  • Computational Chemistry

  • DMPK and Physical Sciences

Copyright © 2016 Sygnature Discovery

Website built by AtomicMedia - Design by Freestyle.